The effects of d-amphetamine on arousal, cognition, and mood after prolonged total sleep deprivation - PubMed (original) (raw)
Clinical Trial
The effects of d-amphetamine on arousal, cognition, and mood after prolonged total sleep deprivation
P A Newhouse et al. Neuropsychopharmacology. 1989 Jun.
Abstract
Thirty-six normal male subjects underwent total sleep deprivation for 48 hours, were then administered either placebo, 5, 10, or 20 mg of d-amphetamine, and sleep deprived for an additional 12 hours. Sleep deprivation produced a significant reduction in sleep latency, as well as marked decrements in cognitive performance and self-ratings reflecting vigor and fatigue. Amphetamine reversed these effects in a dose-related way but the pattern and persistence of the reversal varied across measures. After 20 mg, sleep latency normalized for several hours, but then declined. Behavioral effects tended to follow the pattern of sleep latency. On cognitive tasks, 20 mg produced a sustained return to normal performance in an attentional arithmetic task and a gradual improvement in a verbal reasoning task. The partial temporal dissociation among sleep latency, behavioral, and cognitive effects suggests that varying doses of amphetamine may have time-related differential neurochemical effects or that various dimensions of arousal and alertness may be differentially sensitive to amphetamine.
Similar articles
- Performance and alertness effects of caffeine, dextroamphetamine, and modafinil during sleep deprivation.
Wesensten NJ, Killgore WD, Balkin TJ. Wesensten NJ, et al. J Sleep Res. 2005 Sep;14(3):255-66. doi: 10.1111/j.1365-2869.2005.00468.x. J Sleep Res. 2005. PMID: 16120100 - Behavioral and subjective effects of d-amphetamine and modafinil in healthy adults.
Makris AP, Rush CR, Frederich RC, Taylor AC, Kelly TH. Makris AP, et al. Exp Clin Psychopharmacol. 2007 Apr;15(2):123-33. doi: 10.1037/1064-1297.15.2.123. Exp Clin Psychopharmacol. 2007. PMID: 17469936 Clinical Trial. - Effects of caffeine, sleep loss, and stress on cognitive performance and mood during U.S. Navy SEAL training. Sea-Air-Land.
Lieberman HR, Tharion WJ, Shukitt-Hale B, Speckman KL, Tulley R. Lieberman HR, et al. Psychopharmacology (Berl). 2002 Nov;164(3):250-61. doi: 10.1007/s00213-002-1217-9. Epub 2002 Sep 5. Psychopharmacology (Berl). 2002. PMID: 12424548 Clinical Trial. - The P300 event-related potential. The effects of sleep deprivation.
Morris AM, So Y, Lee KA, Lash AA, Becker CE. Morris AM, et al. J Occup Med. 1992 Dec;34(12):1143-52. J Occup Med. 1992. PMID: 1464782 Review. - Effects of d-amphetamine on arousal.
Chee SJ. Chee SJ. Neurosci Biobehav Rev. 1992 Winter;16(4):481-96. doi: 10.1016/s0149-7634(05)80189-7. Neurosci Biobehav Rev. 1992. PMID: 1480344 Review.
Cited by
- Distinct acute effects of LSD, MDMA, and D-amphetamine in healthy subjects.
Holze F, Vizeli P, Müller F, Ley L, Duerig R, Varghese N, Eckert A, Borgwardt S, Liechti ME. Holze F, et al. Neuropsychopharmacology. 2020 Feb;45(3):462-471. doi: 10.1038/s41386-019-0569-3. Epub 2019 Nov 16. Neuropsychopharmacology. 2020. PMID: 31733631 Free PMC article. - Lisdexamfetamine dimesylate improves processing speed and memory in cognitively impaired MS patients: a phase II study.
Morrow SA, Smerbeck A, Patrick K, Cookfair D, Weinstock-Guttman B, Benedict RH. Morrow SA, et al. J Neurol. 2013 Feb;260(2):489-97. doi: 10.1007/s00415-012-6663-7. Epub 2012 Sep 23. J Neurol. 2013. PMID: 23001556 Clinical Trial. - Caffeine reversal of sleep deprivation effects on alertness and mood.
Penetar D, McCann U, Thorne D, Kamimori G, Galinski C, Sing H, Thomas M, Belenky G. Penetar D, et al. Psychopharmacology (Berl). 1993;112(2-3):359-65. doi: 10.1007/BF02244933. Psychopharmacology (Berl). 1993. PMID: 7871042 Clinical Trial. - Orienting and alerting: effect of 24 h of prolonged wakefulness.
Casagrande M, Martella D, Di Pace E, Pirri F, Guadalupi F. Casagrande M, et al. Exp Brain Res. 2006 May;171(2):184-93. doi: 10.1007/s00221-005-0269-6. Epub 2005 Nov 25. Exp Brain Res. 2006. PMID: 16308689 - Effects of dexamphetamine with and without alcohol on simulated driving.
Simons R, Martens M, Ramaekers J, Krul A, Klöpping-Ketelaars I, Skopp G. Simons R, et al. Psychopharmacology (Berl). 2012 Aug;222(3):391-9. doi: 10.1007/s00213-011-2549-0. Epub 2011 Nov 11. Psychopharmacology (Berl). 2012. PMID: 22076246 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources